- Home
- EDSA vs PRPH Comparison
EDSA vs PRPH Comparison
Compare EDSA & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- PRPH
- Stock Information
- Founded
- EDSA 2015
- PRPH 1989
- Country
- EDSA Canada
- PRPH United States
- Employees
- EDSA N/A
- PRPH N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- EDSA Health Care
- PRPH Health Care
- Exchange
- EDSA Nasdaq
- PRPH Nasdaq
- Market Cap
- EDSA 15.9M
- PRPH 17.7M
- IPO Year
- EDSA N/A
- PRPH 1997
- Fundamental
- Price
- EDSA $2.11
- PRPH $0.28
- Analyst Decision
- EDSA Strong Buy
- PRPH
- Analyst Count
- EDSA 2
- PRPH 0
- Target Price
- EDSA $13.00
- PRPH N/A
- AVG Volume (30 Days)
- EDSA 38.0K
- PRPH 1.1M
- Earning Date
- EDSA 08-08-2025
- PRPH 08-13-2025
- Dividend Yield
- EDSA N/A
- PRPH N/A
- EPS Growth
- EDSA N/A
- PRPH N/A
- EPS
- EDSA N/A
- PRPH N/A
- Revenue
- EDSA N/A
- PRPH $5,845,000.00
- Revenue This Year
- EDSA N/A
- PRPH $221.82
- Revenue Next Year
- EDSA N/A
- PRPH N/A
- P/E Ratio
- EDSA N/A
- PRPH N/A
- Revenue Growth
- EDSA N/A
- PRPH N/A
- 52 Week Low
- EDSA $1.55
- PRPH $0.22
- 52 Week High
- EDSA $5.18
- PRPH $3.00
- Technical
- Relative Strength Index (RSI)
- EDSA 42.63
- PRPH 35.31
- Support Level
- EDSA $2.02
- PRPH $0.30
- Resistance Level
- EDSA $2.35
- PRPH $0.35
- Average True Range (ATR)
- EDSA 0.14
- PRPH 0.04
- MACD
- EDSA -0.03
- PRPH -0.01
- Stochastic Oscillator
- EDSA 18.00
- PRPH 1.93
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.